Skip to the page

Data / Form D filings / Genecis Bioindustries Inc.

Genecis Bioindustries Inc.: Form D filings

Genecis Bioindustries Inc., a company in Scarborough, Canada (Federal Level), filed 5 Form D notices with the SEC between 2022 and 2025. The latest, on June 18, 2025, reports $750,000 sold of a $750,000 offering to 6 investors.

SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.

Company details from the filing

Address
633 CORONATION DRIVE, Scarborough, Canada (Federal Level), M1E 2
Phone
(416) 856-6326
Industry
Other
Entity type
Corporation
Incorporated in
Canada (Federal Level)
Revenue range
Decline to Disclose
Exemptions claimed
Rule 506(b)
SEC identifier (CIK)
1938925

Form D filings

FiledTypeOfferingSoldRemainingInvestorsFirst saleFiling
Jun 18, 2025New notice$750,000$750,0006Jun 16, 2025sec.gov
Dec 27, 2024New notice$851,600$851,6007Dec 18, 2024sec.gov
Mar 10, 2023Amendment$3,250,002$3,250,0026Jan 23, 2023sec.gov
Feb 1, 2023New notice$1,500,000$1,500,0001Jan 23, 2023sec.gov
Jul 20, 2022New notice$7,000,000$7,000,00014Jul 5, 2022sec.gov

Executive officers and directors named in the filing

NameRoleNote in the filing
Sean SimpsonDirector
Luna YuExecutive Officer, Director
Rajesh SwaminathanDirector

Every Form D from the week of Jun 16, 2025 · All recent Other filings

Read from SEC EDGAR. Amount sold is what Genecis Bioindustries Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.